DNM1L and Alzheimer disease: Notably, the use of a non-nitrosylatable Drp1 mutant (C644A) prevented mitochondrial fission, synaptic loss, and neuronal cell death, suggesting that targeting the SNO of Drp1 at Cys644 may be a promising therapeutic strategy for AD.